Alexia Verroken

1.9k total citations · 1 hit paper
34 papers, 1.1k citations indexed

About

Alexia Verroken is a scholar working on Clinical Biochemistry, Epidemiology and Infectious Diseases. According to data from OpenAlex, Alexia Verroken has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Clinical Biochemistry, 17 papers in Epidemiology and 11 papers in Infectious Diseases. Recurrent topics in Alexia Verroken's work include Bacterial Identification and Susceptibility Testing (18 papers), Streptococcal Infections and Treatments (10 papers) and Antibiotic Resistance in Bacteria (8 papers). Alexia Verroken is often cited by papers focused on Bacterial Identification and Susceptibility Testing (18 papers), Streptococcal Infections and Treatments (10 papers) and Antibiotic Resistance in Bacteria (8 papers). Alexia Verroken collaborates with scholars based in Belgium, France and Australia. Alexia Verroken's co-authors include Hector Rodriguez‐Villalobos, Ahalieyah Anantharajah, Benoît Kabamba‐Mukadi, Anaïs Scohy, Monique Bodéus, Y. Glupczynski, G. Wauters, Michel Delmée, Pierre‐François Laterre and C. Berhin and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Frontiers in Microbiology.

In The Last Decade

Alexia Verroken

33 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis

2020 408 citations Anaïs Scohy, Ahalieyah Anantharajah et al. Journal of Clinical Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexia Verroken Belgium	15	563	386	329	238	176	34	1.1k
Ryhana Manji United States	15	646 1.1×	294 0.8×	630 1.9×	253 1.1×	119 0.7×	23	1.2k
Kathleen G. Beavis United States	16	644 1.1×	270 0.7×	504 1.5×	133 0.6×	134 0.8×	51	1.2k
Gorm Lisby Denmark	17	296 0.5×	167 0.4×	614 1.9×	40 0.2×	100 0.6×	36	1.0k
Bradly P. Nicholson United States	17	554 1.0×	171 0.4×	681 2.1×	120 0.5×	192 1.1×	36	1.4k
Dominick Cavuoti United States	15	537 1.0×	299 0.8×	311 0.9×	33 0.1×	373 2.1×	45	1.0k
Nancy S. Miller United States	20	568 1.0×	135 0.3×	411 1.2×	78 0.3×	153 0.9×	43	1.1k
Achim J. Kaasch Germany	18	640 1.1×	417 1.1×	526 1.6×	23 0.1×	285 1.6×	68	1.2k
Maureen H. Diaz United States	23	255 0.5×	61 0.2×	720 2.2×	66 0.3×	120 0.7×	44	1.5k
Nasikarn Angkasekwinai Thailand	15	711 1.3×	24 0.1×	525 1.6×	97 0.4×	233 1.3×	47	1.3k
Isabel Montesinos Belgium	19	731 1.3×	105 0.3×	306 0.9×	98 0.4×	16 0.1×	51	953

Countries citing papers authored by Alexia Verroken

Since Specialization

Citations

This map shows the geographic impact of Alexia Verroken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexia Verroken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexia Verroken more than expected).

Fields of papers citing papers by Alexia Verroken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexia Verroken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexia Verroken. The network helps show where Alexia Verroken may publish in the future.

Co-authorship network of co-authors of Alexia Verroken

This figure shows the co-authorship network connecting the top 25 collaborators of Alexia Verroken. A scholar is included among the top collaborators of Alexia Verroken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexia Verroken. Alexia Verroken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Donat, Nicolas, et al.. (2025). Management and Prevention of Multidrug-Resistant Bacteria in War Casualties. Tropical Medicine and Infectious Disease. 10(5). 128–128. 1 indexed citations

Gheysens, Olivier, François Jamar, Halil Yıldız, et al.. (2024). Impact of [18F] FDG PET/CT on outcomes in patients with Staphylococcus aureus bacteremia: A retrospective single-center experience. Infectious Diseases Now. 54(7). 104977–104977.

Verroken, Alexia, Julien Favresse, Ahalieyah Anantharajah, et al.. (2024). Optimized Antibiotic Management of Critically Ill Patients with Severe Pneumonia Following Multiplex Polymerase Chain Reaction Testing: A Prospective Clinical Exploratory Trial. Antibiotics. 13(1). 67–67. 4 indexed citations

Verroken, Alexia, et al.. (2024). Evaluation of a new protocol for rapid identification of Streptococcus pneumoniae in blood cultures using the modified bile solubility test: Gram staining is still standing. Journal of Clinical Microbiology. 63(1). e0122224–e0122224. 2 indexed citations

Rodriguez‐Villalobos, Hector, et al.. (2024). Comparison of two commercial broth microdilution panels for multidrug-resistant Gram-negative bacteria: Thermo Scientific™ Sensititre DKMGN vs. Beckman Coulter MicroScan NMDRM1. Frontiers in Microbiology. 15. 1480687–1480687. 3 indexed citations

Liu, Xin, Suzanne L. Parker, Alexia Verroken, et al.. (2023). Population pharmacokinetics and dosing simulations of total and unbound temocillin in the plasma and CSF of neurocritically ill patients with external ventricular drain-related cerebral ventriculitis. Journal of Antimicrobial Chemotherapy. 79(2). 429–442. 1 indexed citations

Duprez, Thierry, Ludovic Gérard, Christine Collienne, et al.. (2023). Severe Neurological Involvement in an Adult with Shiga Toxin-Producing Escherichia coli-Hemolytic Uremic Syndrome Treated with Eculizumab. Case Reports in Nephrology and Dialysis. 13(1). 7–14. 2 indexed citations

Anantharajah, Ahalieyah, Frédéric Goormaghtigh, Başak Güler, et al.. (2023). Long-term intensive care unit outbreak of carbapenemase-producing organisms associated with contaminated sink drains. Journal of Hospital Infection. 143. 38–47. 15 indexed citations

Verroken, Alexia, et al.. (2022). Performance evaluation of the FAST™ System and the FAST-PBC Prep™ cartridges for speeded-up positive blood culture testing. Frontiers in Microbiology. 13. 982650–982650. 8 indexed citations

10.

Belkhir, Leïla, et al.. (2022). Helicobacter canis: A Review of Microbiological and Clinical Features. Frontiers in Microbiology. 12. 814944–814944. 7 indexed citations

11.

Berardis, Silvia, et al.. (2020). SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis. Journal of Cystic Fibrosis. 19(6). 872–874. 14 indexed citations

12.

Scohy, Anaïs, Ahalieyah Anantharajah, Monique Bodéus, et al.. (2020). Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. Journal of Clinical Virology. 129. 104455–104455. 408 indexed citations breakdown →

13.

Rodriguez‐Villalobos, Hector, et al.. (2019). Rapid antimicrobial susceptibility testing on positive blood cultures through an innovative light scattering technology: performances and turnaround time evaluation. BMC Infectious Diseases. 19(1). 989–989. 19 indexed citations

14.

Verroken, Alexia, et al.. (2019). The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study. PLoS ONE. 14(9). e0223122–e0223122. 37 indexed citations

15.

Anantharajah, Ahalieyah, et al.. (2019). Evaluation of the automated BD Phoenix CPO Detect test for detection and classification of carbapenemases in Gram negatives. Diagnostic Microbiology and Infectious Disease. 96(2). 114911–114911. 10 indexed citations

16.

Anantharajah, Ahalieyah, et al.. (2019). Performance Evaluation of the MBT STAR®-Carba IVD Assay for the Detection of Carbapenemases With MALDI-TOF MS. Frontiers in Microbiology. 10. 1413–1413. 19 indexed citations

17.

Verroken, Alexia, et al.. (2018). Fatal thoracic empyema involving Campylobacter rectus : A case report. Anaerobe. 49. 95–98. 14 indexed citations

18.

Tré‐Hardy, Marie, et al.. (2017). MALDI-TOF MS identification and antimicrobial susceptibility testing directly from positive enrichment broth. Journal of Microbiological Methods. 141. 32–34. 5 indexed citations

19.

Verroken, Alexia, Olivier le Polain de Waroux, Leïla Belkhir, et al.. (2016). Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures. PLoS ONE. 11(5). e0156299–e0156299. 72 indexed citations

20.

Verroken, Alexia, et al.. (2014). Reducing time to identification of positive blood cultures with MALDI-TOF MS analysis after a 5-h subculture. European Journal of Clinical Microbiology & Infectious Diseases. 34(2). 405–413. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact